Emerging roles of DDB2 in cancer - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue International Journal of Molecular Sciences Année : 2019

Emerging roles of DDB2 in cancer

Résumé

Damage-specific DNA-binding protein 2 (DDB2) was originally identified as a DNA damage recognition factor that facilitates global genomic nucleotide excision repair (GG-NER) in human cells. DDB2 also contributes to other essential biological processes such as chromatin remodeling, gene transcription, cell cycle regulation, and protein decay. Recently, the potential of DDB2 in the development and progression of various cancers has been described. DDB2 activity occurs at several stages of carcinogenesis including cancer cell proliferation, survival, epithelial to mesenchymal transition, migration and invasion, angiogenesis, and cancer stem cell formation. In this review, we focus on the current state of scientific knowledge regarding DDB2 biological effects in tumor development and the underlying molecular mechanisms. We also provide insights into the clinical consequences of DDB2 activity in cancers.

Domaines

Cancer
Fichier principal
Vignette du fichier
ijms-20-05168.pdf (1.05 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-02325073 , version 1 (25-10-2023)

Licence

Paternité

Identifiants

Citer

Pauline Gilson, Guillaume Drouot, Andréa Witz, Jean-Louis Merlin, Philippe Becuwe, et al.. Emerging roles of DDB2 in cancer. International Journal of Molecular Sciences, 2019, 20 (20), pp.5168. ⟨10.3390/ijms20205168⟩. ⟨hal-02325073⟩
81 Consultations
5 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More